Hypotrichosis with juvenile macular degeneration

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1573OMIM:601553Q84.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hypotrichosis with juvenile macular degeneration (HJMD), also known as hypotrichosis with juvenile macular dystrophy, is a rare autosomal recessive disorder characterized by the combination of sparse hair (hypotrichosis) present from early childhood and progressive degeneration of the macula of the eye beginning in the first or second decade of life. The condition is caused by mutations in the CDH3 gene, which encodes P-cadherin, a calcium-dependent cell adhesion protein expressed in the retinal pigment epithelium and hair follicles. Affected individuals typically present with sparse, short scalp hair from birth or early infancy. The hair is often fine, fragile, and slow-growing, and may also affect eyebrows, eyelashes, and body hair. The macular dystrophy usually becomes apparent during childhood or adolescence, with progressive loss of central vision that can lead to legal blindness by early adulthood. Retinal findings include macular atrophy, pigmentary changes, and loss of the foveal reflex. Peripheral vision is generally preserved. There is currently no cure or specific treatment for HJMD. Management is supportive and includes regular ophthalmologic monitoring, low-vision aids, and adaptive strategies for visual impairment. Genetic counseling is recommended for affected families. The condition does not typically affect other organ systems or life expectancy. Early diagnosis through genetic testing of the CDH3 gene can help families prepare for the progressive visual decline and access appropriate support services.

Also known as:

Clinical phenotype terms— hover any for plain English:

Macular degenerationHP:0000608Brittle hairHP:0002299Abnormal limb bone morphologyHP:0002813Pili tortiHP:0003777Abnormal macular pigmentationHP:0008002Immunologic hypersensitivityHP:0100326
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hypotrichosis with juvenile macular degeneration.

View clinical trials →

No actively recruiting trials found for Hypotrichosis with juvenile macular degeneration at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hypotrichosis with juvenile macular degeneration community →

No specialists are currently listed for Hypotrichosis with juvenile macular degeneration.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hypotrichosis with juvenile macular degeneration.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hypotrichosis with juvenile macular degenerationForum →

No community posts yet. Be the first to share your experience with Hypotrichosis with juvenile macular degeneration.

Start the conversation →

Latest news about Hypotrichosis with juvenile macular degeneration

No recent news articles for Hypotrichosis with juvenile macular degeneration.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hypotrichosis with juvenile macular degeneration

What is Hypotrichosis with juvenile macular degeneration?

Hypotrichosis with juvenile macular degeneration (HJMD), also known as hypotrichosis with juvenile macular dystrophy, is a rare autosomal recessive disorder characterized by the combination of sparse hair (hypotrichosis) present from early childhood and progressive degeneration of the macula of the eye beginning in the first or second decade of life. The condition is caused by mutations in the CDH3 gene, which encodes P-cadherin, a calcium-dependent cell adhesion protein expressed in the retinal pigment epithelium and hair follicles. Affected individuals typically present with sparse, short s

How is Hypotrichosis with juvenile macular degeneration inherited?

Hypotrichosis with juvenile macular degeneration follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hypotrichosis with juvenile macular degeneration typically begin?

Typical onset of Hypotrichosis with juvenile macular degeneration is childhood. Age of onset can vary across affected individuals.